{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:58:01Z","timestamp":1761058681089},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1007\/s11882-001-0044-0","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T16:55:01Z","timestamp":1180803301000},"page":"329-336","source":"Crossref","is-referenced-by-count":10,"title":["Autoimmunity in chronic urticaria and urticarial vasculitis"],"prefix":"10.1007","volume":"1","author":[{"given":"Diane C.","family":"Napoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore M.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"44_CR1","first-page":"1409","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"NA Soter","year":"1999","unstructured":"Soter NA: Urticaria and angioedema. In Fitzpatrick\u2019s Dermatology in General Medicine edn 5. Edited by Freedberg IM, Eisen A, Wolff K, et al. New York: McGraw-Hill; 1999:1409\u20131419.","edition":"edn 5"},{"key":"44_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/path.1711640402","volume":"164","author":"PA Hall","year":"1991","unstructured":"Hall PA, Lemoine NR: Koch\u2019s postulates revisited. J Pathol 1991, 164:283\u2013284.","journal-title":"J Pathol"},{"key":"44_CR3","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.1957.02980130015004","volume":"164","author":"E Witebsky","year":"1957","unstructured":"Witebsky E, Rose NR, Terplan K, et al.: Chronic thyroiditis and autoimmunization. JAMA 1957, 164:1439\u20131447.","journal-title":"JAMA"},{"key":"44_CR4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","volume":"14","author":"NR Rose","year":"1993","unstructured":"Rose NR, Bona C: Defining criteria for autoimmune diseases (Witebsky\u2019s postulates revisited). Immunol Today 1993, 14:426\u2013430.","journal-title":"Immunol Today"},{"key":"44_CR5","first-page":"3","volume":"12","author":"P Hewins","year":"2000","unstructured":"Hewins P, Tervaert JWC, Savage COS, Kallenberg CGM: Is Wegener\u2019s granulomatosis an autoimmune disease? Rheumatology 2000, 12:3\u201310.","journal-title":"Rheumatology"},{"key":"44_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0091-6749(71)90089-3","volume":"48","author":"NJ Isaacs","year":"1971","unstructured":"Isaacs NJ, Ertel NH: Urticaria and pruritus: uncommon manifestations of hyperthyroidism. J Allergy Clin Immunol 1971, 48:73\u201381.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.1983.01650320010007","volume":"119","author":"A Leznoff","year":"1983","unstructured":"Leznoff A, Josse RG, Denburg J, Dolovich J: Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983, 119:636\u2013640.","journal-title":"Arch Dermatol"},{"key":"44_CR8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2230.1987.tb02503.x","volume":"12","author":"SW Lanigan","year":"1987","unstructured":"Lanigan SW, Short P, Moult P: The association of chronic urticaria and thyroid autoimmunity. Clin Exp Dermatol 1987, 12:335\u2013338.","journal-title":"Clin Exp Dermatol"},{"key":"44_CR9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0091-6749(89)90180-2","volume":"84","author":"A Leznoff","year":"1989","unstructured":"Leznoff A, Sussman GL: Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989, 84:66\u201371.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-4362.1997.00187.x","volume":"36","author":"I Turktas","year":"1997","unstructured":"Turktas I, Gokcora N, Demirsoy S, et al.: The association of chronic urticaria and angioedema with autoimmune thyroiditis. Int J Dermatol 1997, 36:187\u2013190.","journal-title":"Int J Dermatol"},{"key":"44_CR11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0091-6749(95)70226-1","volume":"96","author":"JS Rumbyrt","year":"1995","unstructured":"Rumbyrt JS, Katz JL, Schocket AL: Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995, 96:901\u2013905.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2230.1995.tb01342.x","volume":"20","author":"S Peltz","year":"1995","unstructured":"Peltz S, Barchuk W, Oppenheimer J, et al.: Chronic angioedema of the tongue associated with pernicious anemia and Hashimoto\u2019s thyroiditis. Clin Exp Dermatol 1995, 20:351\u2013352.","journal-title":"Clin Exp Dermatol"},{"key":"44_CR13","first-page":"528","volume":"29","author":"CK Koh","year":"2000","unstructured":"Koh CK, Hew FL, Chiu CL: Treatment of chronic urticaria with thyroxine in an euthyroid patient with thyroglobulin and microsomal antibodies. Ann Acad Med Singapore 2000, 29:528\u2013530.","journal-title":"Ann Acad Med Singapore"},{"key":"44_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1986.tb04065.x","volume":"114","author":"CEH Grattan","year":"1986","unstructured":"Grattan CEH, Wallington TB, Warin RP, et al.: A serological mediator in chronic idiopathic urticaria- a clinical, immunological and histological evaluation. Br J Dermatol 1986, 114:583\u2013590.","journal-title":"Br J Dermatol"},{"key":"44_CR15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1523-1747.ep12462239","volume":"90","author":"BL Gruber","year":"1988","unstructured":"Gruber BL, Baeza ML, Marchese MJ, et al.: Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988, 90:213\u2013217.","journal-title":"J Invest Dermatol"},{"key":"44_CR16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2222.1991.tb03198.x","volume":"21","author":"CEH Grattan","year":"1991","unstructured":"Grattan CEH, Francis DM, Hide M, Greaves MW: Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991, 21:695\u2013704.","journal-title":"Clin Exp Allergy"},{"key":"44_CR17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","volume":"328","author":"M Hide","year":"1993","unstructured":"Hide M, Francis DM, Grattan CEH, et al.: Autoantibodies against the high-affinity ige receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993, 328:1599\u20131604.","journal-title":"N Engl J Med"},{"key":"44_CR18","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1172\/JCI118325","volume":"96","author":"E Fiebiger","year":"1995","unstructured":"Fiebiger E, Maurer D, Holub H, et al.: Serum IgG autoantibodies directed against the a chain of FceRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995, 96:2606\u20132612.","journal-title":"J Clin Invest"},{"key":"44_CR19","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1523-1747.ep12338544","volume":"106","author":"N Niimi","year":"1996","unstructured":"Niimi N, Francis DM, Kermani F, et al.: Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996, 106:1001\u20131006.","journal-title":"J Invest Dermatol"},{"key":"44_CR20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","volume":"101","author":"M Ferrer","year":"1998","unstructured":"Ferrer M, Kinet JP, Kaplan A: Comparative studies of functional and binding assays for IgG anti-FceRIa (a-subunit) in chronic urticaria. J Allergy Clin Immunol 1998, 101:672\u2013676. This comparative study used sera from 68 patients with CIU to release histamine from donor basophils and dispersed human mast cells, demonstrating a significant correlation between the two different assays.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0091-6749(97)70071-X","volume":"99","author":"LJ Tong","year":"1997","unstructured":"Tong LJ, Balakrishnan G, Kochan JP, et al.: Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997, 99:461\u2013465.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","volume":"101","author":"E Fiebiger","year":"1998","unstructured":"Fiebiger E, Hammerschmid F, Stingl G, Maurer D: Anti-FceRIa autoantibodies in autoimmune-mediated disorders. J Clin Invest 1998, 101:243\u2013251. Patients with CIU and other autoimmune diseases were evaluated for the presence of anti-FceRIa using an ELISA-based assay. Although these autoantibodies can be found in other autoimmune diseases, only sera from patients with CIU and anti-FceRIa autoantibodies released histamine. The IgG subtype of the anti-FceRIa autoantibodies in CIU was further characterized as IgG1 and IgG3, and the authors present data suggesting a role for complement.","journal-title":"J Clin Invest"},{"key":"44_CR23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0091-6749(99)70129-6","volume":"104","author":"M Ferrer","year":"1999","unstructured":"Ferrer M, Nakazawa K, Kaplan A: Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999, 104:169\u2013172. The role for complement was investigated using histamine release from dispersed mast cells in response to untreated sera, heated sera (decomplemented), or isolated IgG from sera of patients with CIU. Only sera of patients with CIU or isolated IgG of patients with CIU combined with normal serum were able to release significantly more histamine than the control.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1139::AID-IMMU1139>3.0.CO;2-J","volume":"29","author":"MP Horn","year":"1999","unstructured":"Horn MP, Gerster T, Ochensberger B, et al.: Human anti-FceRIa autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999, 29:1139\u20131148. Two different commercial multidonor IgG preparations were examined for anti-FceRIa autoantibodies. The autoantibodies were present and cross-reacted with tetanus toxoid but did not release histamine from donor basophils.","journal-title":"Eur J Immunol"},{"key":"44_CR25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1067\/mai.2000.108913","volume":"106","author":"U Fagiolo","year":"2000","unstructured":"Fagiolo U, Kricek F, Ruf C, et al.: Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000, 106:567\u2013572. Using sera from 15 patients with CIU and a positive ASST, it was demonstrated that 1) 14 sera had anti-FceRIa autoantibodies, 2) only sera from two patients released histamine from donor basophils, and 3) the ASST in these patients was unaffected by heat-treated\/IgG-depleted sera. This study suggests that a positive ASST may be due to other HRFs present in the sera of CIU patients.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000235301","volume":"93","author":"CEH Grattan","year":"1990","unstructured":"Grattan CEH, Boon AP, Eady RAJ, Winkelmann RK: The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 1990, 93:198\u2013204.","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"44_CR27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2133.1999.02707.x","volume":"140","author":"RA Sabroe","year":"1999","unstructured":"Sabroe RA, Grattan CEH, Francis DM, et al.: The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999, 140:446\u2013452. The sensitivity and specificity of different parameters of the positive ASST were calculated for use in identifying patients with autoantibodies.","journal-title":"Br J Dermatol"},{"key":"44_CR28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/mai.2000.104939","volume":"105","author":"B Wedi","year":"2000","unstructured":"Wedi B, Novacovic V, Koerner M, Kapp A: Chronic urticaria serum induces histamine release, leukotriene production, basophil CD63 surface expression-inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000, 105:552\u2013560. This article compared the sera from patients with CIU and a positive ASST, from patients with CIU and a negative ASST, and from atopic and nonatopic control subjects for its ability to release histamine using atopic and nonatopic donor cells. Additionally, basophil activation using surface expression of CD63 and leukotriene production was examined.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR29","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0140-6736(92)90666-Q","volume":"339","author":"CEH Grattan","year":"1992","unstructured":"Grattan CEH, Francis DM, Slater NGP, et al.: Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992, 339:1078\u20131080.","journal-title":"Lancet"},{"key":"44_CR30","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-2222.1997.tb02986.x","volume":"27","author":"CEH Grattan","year":"1997","unstructured":"Grattan CEH, Walpole D, Francis DM, et al.: Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997, 27:1417\u20131424.","journal-title":"Clin Exp Allergy"},{"key":"44_CR31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2133.1998.02033.x","volume":"138","author":"BF O\u2019Donnell","year":"1998","unstructured":"O\u2019Donnell BF, Barr RM, Black AK, et al.: Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998, 138:101\u2013106. Three of 10 patients with severe CIU were successfully treated using IVIg. Treatment options are offered.","journal-title":"Br J Dermatol"},{"key":"44_CR32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/000155500750012540","volume":"80","author":"M Kroiss","year":"2000","unstructured":"Kroiss M, Vogt T, Landthaler M, Stolz W: The effectiveness of low-dose intravenous immunoglobulin in chronic urticaria. Acta Derm Venereol 2000, 80:225.","journal-title":"Acta Derm Venereol"},{"key":"44_CR33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1997.tb00996.x","volume":"52","author":"E Toubi","year":"1997","unstructured":"Toubi E, Blant A, Kessel A, Golan TD: Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997, 52:312\u2013316.","journal-title":"Allergy"},{"key":"44_CR34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","volume":"143","author":"CEH Grattan","year":"2000","unstructured":"Grattan CEH, O\u2019Donnell BF, Francis DM, et al.: Randomized double-blind study of cyclosporin in chronic \u2018idiopathic\u2019 urticaria. Br J Dermatol 2000, 143:365\u2013372. In this initially double-blind study, cyclosporin was used to treat patients with CIU. Eight of 19 patients initially responded to 4 weeks of therapy, but six of the eight relapsed when therapy was discontinued. Only one was still clear at 6 months. All nonresponders and placebo patients were offered open-label cyclosporin. Eleven of 17 responded, with four remaining clear\/almost clear at 6 months. Treatment options are offered in this article.","journal-title":"Br J Dermatol"},{"key":"44_CR35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0738-081X(99)00062-0","volume":"17","author":"AK Black","year":"1999","unstructured":"Black AK: Urticarial vasculitis. Clin Dermatol 1999, 17:565\u2013569.","journal-title":"Clin Dermatol"},{"key":"44_CR36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00002281-200001000-00005","volume":"12","author":"JJ Wisnieski","year":"2000","unstructured":"Wisnieski JJ: Urticarial vasculitis. Curr Opin Rheumatol 2000, 12:24\u201331. This is a good overall review of UV.","journal-title":"Curr Opin Rheumatol"},{"key":"44_CR37","first-page":"313","volume-title":"Cutaneous Allergy","author":"T Freeman","year":"1996","unstructured":"Freeman T: Cutaneous vasculitis. In Cutaneous Allergy. Edited by Charlesworth EN. Malden: Blackwell Science; 1996:313\u2013329."},{"key":"44_CR38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1034\/j.1398-9995.2000.00445.x","volume":"55","author":"T Zuberbier","year":"2000","unstructured":"Zuberbier T, Henz BM, Fiebiger E, et al.: Anti- FceRIa serum autoantibodies in different subtypes of urticaria. Allergy 2000, 55:951\u2013954. This is another study demonstrating the presence of anti-FceRIa autoantibodies in CIU.","journal-title":"Allergy"},{"key":"44_CR39","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/anr.1780320910","volume":"32","author":"JJ Wisnieski","year":"1989","unstructured":"Wisnieski JJ, Naff GB: Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 1989, 32:1119\u20131127.","journal-title":"Arthritis Rheum"},{"key":"44_CR40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","volume":"26","author":"DR Mehregan","year":"1992","unstructured":"Mehregan DR, Hall MJ, Gibson LE: Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992, 26:441\u2013448.","journal-title":"J Am Acad Dermatol"},{"key":"44_CR41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00005792-199501000-00003","volume":"74","author":"JJ Wisnieski","year":"1995","unstructured":"Wisnieski JJ, Baer AN, Christensen J, et al.: Hypocomplementemic urticarial vasculitis syndrome: clinical and serologic findings in 18 patients. Medicine 1995, 74:24\u201341.","journal-title":"Medicine"},{"key":"44_CR42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2133.1999.02815.x","volume":"140","author":"BF O\u2019Donnell","year":"1999","unstructured":"O\u2019Donnell BF, O\u2019Neill CM, Francis DM, et al.: Human leukocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999, 140:853\u2013858.","journal-title":"Br J Dermatol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-001-0044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-001-0044-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-001-0044-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:38:32Z","timestamp":1559432312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-001-0044-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1007\/s11882-001-0044-0","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}